Answers are grounded in this paper and cite their sources.
A young woman with immune thrombocytopenia (ITP) who has been treated with a thrombopoietin-receptor agonist presents for advice regarding long-term treatment. The agents in this therapeutic class, romiplostim and eltrombopag, are effective in increasing platelet counts.
No takes yet. Share an insight, caveat, or question.
Imbach et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: